Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.
Authors: Chodick G,  Struewing JP,  Ron E,  Rutter JL,  Iscovich J
Journal: Eur J Med Genet
Date: 2008 Mar-Apr
Branches: CGB, REB
PubMed ID: 18158280
PMC ID: PMC2386175
Abstract: To evaluate the potential contribution of mutations in the BRCA1 and BRCA2 genes to male breast cancer (MBC), we expanded a previous study to screen a total of 261 Israeli men diagnosed with breast carcinoma. A total of 21 BRCA2 6174delT and 8 BRCA1 185delAG mutations were found. Similar frequencies of BRCA1 and BRCA2 mutation carriers were found among Ashkenazi (12.8%) and non-Ashkenazi Jews (9.1%). The combined prevalence of BRCA1/BRCA2 founder mutations among Ashkenazi Jewish men is slightly higher than for women, due to a higher frequency of BRCA2 mutations.